-
1
-
-
33847638137
-
Estimates of the cancer incidence and mortality in Europe in 2006
-
Ferlay J, Autier P, Boniol M et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-592.
-
(2007)
Ann Oncol
, vol.18
, pp. 581-592
-
-
Ferlay, J.1
Autier, P.2
Boniol, M.3
-
2
-
-
0036137150
-
Estimates of cancer incidence and mortality in Europe in 1995
-
Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002; 38: 99-166.
-
(2002)
Eur J Cancer
, vol.38
, pp. 99-166
-
-
Bray, F.1
Sankila, R.2
Ferlay, J.3
Parkin, D.M.4
-
3
-
-
0031859317
-
Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997
-
Heald RJ, Moran BJ, Ryall RD et al. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998; 133: 894-899.
-
(1998)
Arch Surg
, vol.133
, pp. 894-899
-
-
Heald, R.J.1
Moran, B.J.2
Ryall, R.D.3
-
4
-
-
0033180254
-
Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients
-
Havenga K, Enker WE, Norstein J et al. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients. Eur J Surg Oncol 1999; 25: 368-374.
-
(1999)
Eur J Surg Oncol
, vol.25
, pp. 368-374
-
-
Havenga, K.1
Enker, W.E.2
Norstein, J.3
-
5
-
-
18444383958
-
A national strategic change in treatment policy for rectal cancer-implementation of total mesorectal excision as routine treatment in Norway. A national audit
-
Wibe A, Moller B, Norstein J et al. A national strategic change in treatment policy for rectal cancer-implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002; 45: 857-866.
-
(2002)
Dis Colon Rectum
, vol.45
, pp. 857-866
-
-
Wibe, A.1
Moller, B.2
Norstein, J.3
-
6
-
-
36849010200
-
The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of rectal cancer
-
Glynne-Jones R, Mathur P, Elton C, Train ML. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of rectal cancer. Best Pract Res Clin Gastroenterol 2007; 21: 1049-1070.
-
(2007)
Best Pract Res Clin Gastroenterol
, vol.21
, pp. 1049-1070
-
-
Glynne-Jones, R.1
Mathur, P.2
Elton, C.3
Train, M.L.4
-
7
-
-
0036204946
-
Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery
-
Birbeck KF, Macklin CP, Tiffin NJ et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002; 235: 449-457.
-
(2002)
Ann Surg
, vol.235
, pp. 449-457
-
-
Birbeck, K.F.1
Macklin, C.P.2
Tiffin, N.J.3
-
8
-
-
33750071992
-
Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational, study
-
MERCURY Study Group
-
MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006; 333: 779.
-
(2006)
BMJ
, vol.333
, pp. 779
-
-
-
9
-
-
18444388842
-
Preoperative staging of rectal cancer: the MERCURY research project
-
Brown G, Daniels IR. Preoperative staging of rectal cancer: the MERCURY research project. Recent Results Cancer Res 2005; 165: 58-74.
-
(2005)
Recent Results Cancer Res
, vol.165
, pp. 58-74
-
-
Brown, G.1
Daniels, I.R.2
-
10
-
-
0029128275
-
Prognostic factors of rectum carcinoma-experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma
-
Hermanek P, Wiebelt H, Staimmer D, Riedl S. Prognostic factors of rectum carcinoma-experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma. Tumori 1995; 81: 60-64.
-
(1995)
Tumori
, vol.81
, pp. 60-64
-
-
Hermanek, P.1
Wiebelt, H.2
Staimmer, D.3
Riedl, S.4
-
11
-
-
33644819648
-
Low rectal cancer: a call for a change of approach in abdominoperineal resection
-
Nagtegaal ID, van de Velde, Marijnen CA et al. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 2005; 23: 9257-9264.
-
(2005)
J Clin Oncol
, vol.23
, pp. 9257-9264
-
-
Nagtegaal, I.D.1
van de Velde2
Marijnen, C.A.3
-
12
-
-
0035975394
-
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
-
Kapiteijn E, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-646.
-
(2001)
N Engl J Med
, vol.345
, pp. 638-646
-
-
Kapiteijn, E.1
Marijnen, C.A.2
Nagtegaal, I.D.3
-
13
-
-
33748676449
-
Chemotherapy with preoperative radiotherapy in rectal cancer
-
Bosset JF, Collette L, Calais G et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-1123.
-
(2006)
N Engl J Med
, vol.355
, pp. 1114-1123
-
-
Bosset, J.F.1
Collette, L.2
Calais, G.3
-
14
-
-
33750580102
-
Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203
-
Gerard JP, Conroy T, Bonnetain F et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006; 24: 4620-4625.
-
(2006)
J Clin Oncol
, vol.24
, pp. 4620-4625
-
-
Gerard, J.P.1
Conroy, T.2
Bonnetain, F.3
-
15
-
-
3242716904
-
Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy
-
Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 2004; 72: 15-24.
-
(2004)
Radiother Oncol
, vol.72
, pp. 15-24
-
-
Bujko, K.1
Nowacki, M.P.2
Nasierowska-Guttmejer, A.3
-
16
-
-
34548557656
-
The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma
-
Peeters KC, Marijnen CA, Nagtegaal ID et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246: 693-701.
-
(2007)
Ann Surg
, vol.246
, pp. 693-701
-
-
Peeters, K.C.1
Marijnen, C.A.2
Nagtegaal, I.D.3
-
17
-
-
49249090949
-
Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer
-
Braendengen M, Tveit KM, Berglund A et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 2008; 26: 3687-3694.
-
(2008)
J Clin Oncol
, vol.26
, pp. 3687-3694
-
-
Braendengen, M.1
Tveit, K.M.2
Berglund, A.3
-
18
-
-
6044226542
-
Preoperative versus postoperative chemoradiotherapy for rectal cancer
-
Sauer R, Becker H, Hohenberger W et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
-
(2004)
N Engl J Med
, vol.351
, pp. 1731-1740
-
-
Sauer, R.1
Becker, H.2
Hohenberger, W.3
-
19
-
-
0043067010
-
The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer
-
Crane CH, Skibber JM, Birnbaum EH et al. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2003; 57: 84-89.
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.57
, pp. 84-89
-
-
Crane, C.H.1
Skibber, J.M.2
Birnbaum, E.H.3
-
20
-
-
77349110719
-
Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRIdefined poor-risk rectal cancer: a phase 2 trial
-
Chua YJ, Barbachano Y, Cunningham D et al. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRIdefined poor-risk rectal cancer: a phase 2 trial. Lancet Oncol 2010; 11: 241-248.
-
(2010)
Lancet Oncol
, vol.11
, pp. 241-248
-
-
Chua, Y.J.1
Barbachano, Y.2
Cunningham, D.3
-
21
-
-
33644846344
-
Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer
-
Chau I, Brown G, Cunningham D et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 2006; 24: 668-674.
-
(2006)
J Clin Oncol
, vol.24
, pp. 668-674
-
-
Chau, I.1
Brown, G.2
Cunningham, D.3
-
22
-
-
33745622869
-
Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation
-
Calvo FA, Serrano FJ, Diaz-Gonzalez JA et al. Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation. Ann Oncol 2006; 17: 1103-1110.
-
(2006)
Ann Oncol
, vol.17
, pp. 1103-1110
-
-
Calvo, F.A.1
Serrano, F.J.2
Diaz-Gonzalez, J.A.3
-
23
-
-
84876076328
-
-
National Institute of Health. NCI: Common Toxicity Criteria, Version 2.0 1998
-
National Institute of Health. NCI: Common Toxicity Criteria, Version 2.0 1998; http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ ctcv20_4-30-992.pdf.
-
-
-
-
24
-
-
29644447540
-
Thin section MRI in multidisciplinary pre-operative decision making for patients with rectal cancer
-
Brown G. Thin section MRI in multidisciplinary pre-operative decision making for patients with rectal cancer. Br J Radiol 2005; 78 (Spec No 2): S117-S127.
-
(2005)
Br J Radiol
, vol.78
, Issue.SPEC NO 2
-
-
Brown, G.1
-
25
-
-
0030990974
-
Pathological features of rectal cancer after preoperative radiochemotherapy
-
Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12: 19-23.
-
(1997)
Int J Colorectal Dis
, vol.12
, pp. 19-23
-
-
Dworak, O.1
Keilholz, L.2
Hoffmann, A.3
-
26
-
-
33845382806
-
Non-parametric estimation from incomplete observations
-
Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Statist Assoc 1958; 53: 457-481.
-
(1958)
J Am Statist Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
27
-
-
80051808651
-
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials
-
Valentini V, van Stiphout RG, Lammering G et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol 2011; 29: 3163-3172.
-
(2011)
J Clin Oncol
, vol.29
, pp. 3163-3172
-
-
Valentini, V.1
van Stiphout, R.G.2
Lammering, G.3
-
28
-
-
79952744347
-
Postgraduate multidisciplinary development program: impact on the interpretation of pelvic MRI in patients with rectal cancer: a clinical audit in West Denmark
-
Pedersen BG, Blomqvist L, Brown G et al. Postgraduate multidisciplinary development program: impact on the interpretation of pelvic MRI in patients with rectal cancer: a clinical audit in West Denmark. Dis Colon Rectum 2011; 54: 328-334.
-
(2011)
Dis Colon Rectum
, vol.54
, pp. 328-334
-
-
Pedersen, B.G.1
Blomqvist, L.2
Brown, G.3
-
29
-
-
0032858192
-
Lymph node size and metastatic infiltration in colon cancer
-
Monig SP, Baldus SE, Zirbes TK et al. Lymph node size and metastatic infiltration in colon cancer. Ann Surg Oncol 1999; 6: 579-581.
-
(1999)
Ann Surg Oncol
, vol.6
, pp. 579-581
-
-
Monig, S.P.1
Baldus, S.E.2
Zirbes, T.K.3
-
30
-
-
0037406971
-
Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison
-
Brown G, Richards CJ, Bourne MW et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 2003; 227: 371-377.
-
(2003)
Radiology
, vol.227
, pp. 371-377
-
-
Brown, G.1
Richards, C.J.2
Bourne, M.W.3
-
31
-
-
42949150908
-
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer
-
Cassidy J, Clarke S, Diaz-Rubio E et al. Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer. J Clin Oncol 2008; 26: 2006-2012.
-
(2008)
J Clin Oncol
, vol.26
, pp. 2006-2012
-
-
Cassidy, J.1
Clarke, S.2
Diaz-Rubio, E.3
-
32
-
-
34948892881
-
Phase III study of capecitabine plus oxaliplatin compared with continuous-infusion fluorouracil plus oxaliplatin as first-line therapy in metastatic colorectal cancer: final report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial
-
Diaz-Rubio E, Tabernero J, Gomez-Espana A et al. Phase III study of capecitabine plus oxaliplatin compared with continuous-infusion fluorouracil plus oxaliplatin as first-line therapy in metastatic colorectal cancer: final report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial. J Clin Oncol 2007; 25: 4224-4230.
-
(2007)
J Clin Oncol
, vol.25
, pp. 4224-4230
-
-
Diaz-Rubio, E.1
Tabernero, J.2
Gomez-Espana, A.3
-
33
-
-
34948857445
-
Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group
-
Porschen R, Arkenau HT, Kubicka S et al. Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group. J Clin Oncol 2007; 25: 4217-4223.
-
(2007)
J Clin Oncol
, vol.25
, pp. 4217-4223
-
-
Porschen, R.1
Arkenau, H.T.2
Kubicka, S.3
-
34
-
-
77956185901
-
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
-
Maas M, Nelemans PJ, Valentini V et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 2010; 11: 835-844.
-
(2010)
Lancet Oncol
, vol.11
, pp. 835-844
-
-
Maas, M.1
Nelemans, P.J.2
Valentini, V.3
-
35
-
-
33747889701
-
Impact of pretreatment size and lymph nodes on pathological complete response and survival in a prospective trial of chemoradiation
-
(Abstr 1034)
-
Kim C, Anne PR, Mitchell E. Impact of pretreatment size and lymph nodes on pathological complete response and survival in a prospective trial of chemoradiation. Int J Radiat Oncol Biol Phys 2005; 632 SupplS164. (Abstr 1034).
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.632
, Issue.SUPPLS164
-
-
Kim, C.1
Anne, P.R.2
Mitchell, E.3
-
36
-
-
58149375105
-
The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer
-
Peschaud F, Benoist S, Julie C et al. The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer. Ann Surg 2008; 248: 1067-1073.
-
(2008)
Ann Surg
, vol.248
, pp. 1067-1073
-
-
Peschaud, F.1
Benoist, S.2
Julie, C.3
-
37
-
-
67649391022
-
The prognostic impact of the number of lymph nodes retrieved after neoadjuvant chemoradiotherapy with mesorectal excision for rectal cancer
-
Kim YW, Kim NK, Min BS et al. The prognostic impact of the number of lymph nodes retrieved after neoadjuvant chemoradiotherapy with mesorectal excision for rectal cancer. J Surg Oncol 2009; 100: 1-7.
-
(2009)
J Surg Oncol
, vol.100
, pp. 1-7
-
-
Kim, Y.W.1
Kim, N.K.2
Min, B.S.3
-
38
-
-
77957325772
-
The effect of neoadjuvant chemoradiation therapy on the prognostic value of lymph nodes after rectal cancer surgery
-
Klos CL, Shellito PC, Rattner DW et al. The effect of neoadjuvant chemoradiation therapy on the prognostic value of lymph nodes after rectal cancer surgery. Am J Surg 2010; 200: 440-445.
-
(2010)
Am J Surg
, vol.200
, pp. 440-445
-
-
Klos, C.L.1
Shellito, P.C.2
Rattner, D.W.3
|